{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:44:45Z","timestamp":1792806285320,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.diabres.2026.113469","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:18:55Z","timestamp":1786029535000},"page":"113469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and tolerability of mirogabalin, pregabalin, duloxetine, and placebo in patients with type 2 diabetes mellitus and painful diabetic peripheral neuropathy: A network meta-analysis"],"prefix":"10.1016","volume":"239","author":[{"given":"Amber","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdia","family":"Gul Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Taha Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Salman Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Shahzaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohaima","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira Arshad","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diabres.2026.113469_b0005","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s40200-020-00661-7","article-title":"Prevalence and associated factors of painful diabetic peripheral neuropathy among diabetic patients on follow up at Jimma University Medical Center","volume":"19","author":"Abdissa","year":"2020","journal-title":"J DiabetesMetab Disord"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of Type 2 Diabetes \u2013 Global Burden of Disease and Forecasted Trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"issue":"6","key":"10.1016\/j.diabres.2026.113469_b0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: Clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.diabres.2026.113469_b0020","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s12020-024-03954-6","article-title":"Healthcare costs and medical utilization patterns associated with painful and severe painful diabetic peripheral neuropathy","volume":"86","author":"Bromberg","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.diabres.2026.113469_b0025","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes\u20142024. Diabetes Care. 2023 Dec 11;47(Supplement_1):S231\u201343. doi:10.2337\/dc24-S012.","DOI":"10.2337\/dc24-S012"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.0000000000013038","article-title":"Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary","volume":"98","author":"Price","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.diabres.2026.113469_b0035","unstructured":"Duloxetine. In: LiverTox\u00ae: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012 [cited 2026 May 23]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548820\/ PubMed PMID: 31644127."},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023600","article-title":"Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials","volume":"9","author":"Onakpoya","year":"2019","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.diabres.2026.113469_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/ejp.70112","article-title":"Mirogabalin for Treatment of Neuropathic Pain and Associated sleep Interference: an Updated Meta-Analysis","volume":"29","author":"Jo\u00e3o","year":"2025","journal-title":"Eur J Pain"},{"issue":"6","key":"10.1016\/j.diabres.2026.113469_b0050","first-page":"262","article-title":"The PRISMA statement extension for systematic reviews incorporating network meta-analysis: PRISMA-NMA","volume":"147","author":"Hutton","year":"2016","journal-title":"Med Cl\u00ednica Engl Ed"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.diabres.2026.113469_b0060","first-page":"e1230","article-title":"PRISMA2020: an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.diabres.2026.113469_b0065","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.diabres.2026.113469_b0070","first-page":"1","article-title":"netmeta: Network Meta-Analysis using Frequentist Methods","volume":"106","author":"R\u00fccker","year":"2023","journal-title":"J Stat Softw"},{"key":"10.1016\/j.diabres.2026.113469_b0075","unstructured":"Meta\u2010Analysis in R - Systematic Reviews in Health Research - Wiley Online Library [Internet]. [cited 2026 May 21]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9781119099369.ch26."},{"key":"10.1016\/j.diabres.2026.113469_b0080","doi-asserted-by":"crossref","unstructured":"A guide and pragmatic considerations for applying GRADE to network meta-analysis | The BMJ [Internet]. [cited 2026 May 21]. Available from: https:\/\/www.bmj.com\/content\/381\/bmj-2022-074495.abstract.","DOI":"10.1136\/bmj-2022-074495"},{"issue":"1\u20132","key":"10.1016\/j.diabres.2026.113469_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.diabres.2026.113469_b0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"issue":"8","key":"10.1016\/j.diabres.2026.113469_b0095","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.diabres.2026.113469_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/ph14020112","article-title":"Mirogabalin-a Novel Selective Ligand for the \u03b12\u03b4 Calcium Channel Subunit","volume":"14","author":"Zaj\u0105czkowska","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.diabres.2026.113469_b0105","first-page":"1299","article-title":"Mirogabalin for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phaseIII study in asian patients","volume":"10","author":"Baba","year":"2019","journal-title":"J DiabetesInvestig"},{"issue":"2","key":"10.1016\/j.diabres.2026.113469_b0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.diabres.2026.113469_b0115","article-title":"Optimising the Therapeutic Window: a Systematic Review and Network Meta-Analysis of Pregabalin Dosing strategies for Painful Diabetic Neuropathy","author":"Kwon","year":"2026","journal-title":"DiabetesObes Metab"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth","year":"2014","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"10.1016\/j.diabres.2026.113469_b0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"Feldman","year":"2019","journal-title":"Diabetic neuropathy Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic Neuropathy: a Position Statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2026.113469_b0140","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/ph16071017","article-title":"Efficacy of Pregabalin and Duloxetine in patients with Painful Diabetic Peripheral Neuropathy (PDPN): a Multi-Centre phase IV Clinical Trial-BLOSSOM","volume":"16","author":"Rakusa","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.diabres.2026.113469_b0145","article-title":"Which treatment modality offers the best outcomes for diabetic retinopathy? a systematic review and network meta-analysis","volume":"227","author":"Chen","year":"2025","journal-title":"Diabetes ResClin Pract"},{"issue":"11","key":"10.1016\/j.diabres.2026.113469_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2025.109178","article-title":"Can fibrate therapy redefine the management of diabetic retinopathy? a comprehensive systematic review and meta-analysis of efficacy and safety","volume":"39","author":"Chen","year":"2025","journal-title":"J Diabetes Complications"},{"issue":"10","key":"10.1016\/j.diabres.2026.113469_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2025.100632","article-title":"Association between omega-3 fatty acid intake and risk of diabetic retinopathy: a systematic review and meta-analysis","volume":"29","author":"Chen","year":"2025","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"10.1016\/j.diabres.2026.113469_b0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12911-025-03119-z","article-title":"Can artificial intelligence with multimodal imaging outperform traditional methods in predicting age-related macular degeneration progression? a systematic review and exploratory meta-analysis","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272600389X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272600389X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:17:58Z","timestamp":1792804678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272600389X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S016882272600389X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113469","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of mirogabalin, pregabalin, duloxetine, and placebo in patients with type 2 diabetes mellitus and painful diabetic peripheral neuropathy: A network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113469","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113469"}}